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In human impetigo, Group A beta hemolytic streptococci and Staphylococcus aureus 
are the organisms most frequently implicated as etiologic  agents (1-8). The majority 
of S. aureus strains recovered in pure form from skin lesions belong to phage Type 71 
(1, 2, 5-7, 9).  Strains of this staphylococcal phage Type have a number of unusuM 
biological activities. Penicillin  G resistance is common among phage Type 71 staphylo- 
cocci (5, 9). These organisms produce opacity in horse serum agar but not in egg yolk 
broth medium (9).  On solid media, Corynebacterium diphtheriae is inhibited by these 
staphylococci (1, 9). 
In previous work from our laboratory a bactericidal substance active in vitro against 
a variety of Gram-positive microorganisms has been isolated from culture supernates 
of phage Type 71 staphylococci (10, 11). This extracellular proteinaceous material has 
properties characteristic of some classes  of bacteriocins (11). It inhibits protein and 
DNA synthesis and degrades RNA in susceptible cells (12), with concomitant changes 
in intracellular appearance (13). 
The present communication  is an extension of these in vitro studies. It documents 
the bactericidal effect  of phage Type 71  staphylococci in vivo. The interaction be- 
tween Group A streptococci and staphylococci is explored in an experimental hamster 
model for impetigo (14,  15)  used previously in this laboratory to study the natural 
history of the infection (15) and the effect of various therapeutic regimens (16). 
Materials and Methods 
Organisms.--Two strains of Group A beta hemolytic streptococci were used. PF 1643, an 
M Type 57 strain, was isolated from a skin lesion of a patient who subsequently developed 
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acute glomerulonephritis. Strain 70-711 is M Type 12 and was isolated from a blood culture of 
a patient at Hennepin  County General Hospital, Minneapolis, Minn. Both strains were grown 
in Todd-Hewitt  broth (Difco Laboratories~ Inc., Detroit,  Mich.) for 6 hr at 37°C and 2 ml 
portions were then stored at -- 65°C until needed. Before use, specimens  were thawed, reinocu- 
lated  into fresh Todd-Hewitt  broth,  grown for 4-6 hr at 37°C, and the number of viable 
colony-forming units (CFU)  1  per milliliter determined. 
The three Staphylococcus  aureus strains employed were of different phage types. Strain C55, 
used as a prototype  of phage Type 71 staphylococci in these studies, was isolated from an 
impetiginous lesion and has been shown to produce a bactericidal substance in vitro (10, 11). 
Strains RL 995 and RL 3809 are phage Types 75 and 81, respectively, and were also originally 
isolated from lesions of the skin. Neither of these latter two strains produces a bactericidal 
substance as tested by the in vitro method described previously. All staphylococcal strains 
were grown in tryptic soy broth (TSB) (Difco) and stored as above for the streptococcal 
strains. 
Assay for  Bactericidal  Substance.--The  lawn-spotting  method  for  bactericidal  activity 
against Group A streptococci was used as previously described (10). Supernatant fluids from 
24-36 hr cultures of the staphylococcal strains in TSB were employed (10, 11). 
Animal Inoculation.--The method for production of skin lesions in Syrian hamsters was 
reported previously (15). In brief, 0.1 ml of a 4-6 hr culture of the various organisms, or mix- 
tures of organisms, were injected intradermally  into the shaved backs of hamsters using a 
27-gauge needle on a tuberculin syringe. Each animal was injected at four sites at least 3 cm 
apart. 
Quantitation of Bacteria in Lesions.--Cultures from lesions were obtained  after removal of 
scabs if present. A calibrated platinum  loop, delivering 0.001 ml, was used to transfer material 
from the base of a lesion to 1.0 ml of sterile 0.85% NaC1 solution. After adequate  mixing, 
serial dilutions were made in the saline and 0.1 ml portions from various dilutions were plated 
immediately onto the surface of blood agar with and without crystal violet (1 : l0  s final con- 
centration). Mter incubation at 37°C for 18-24 hr, the number of viable CFU per loop was 
calculated. 
I~ESLILTS 
To assess  the effect  of  various strains  of  staphylococci on the survival of 
streptococci in experimental lesions, mixtures of  the  two  organisms were in- 
jected into the skin of hamsters. A  suspension of logarithmic-phase organisms 
of M  Type 57  streptococcus containing 1.2  X  l0  s CFU/ml were mixed with 
equal volumes of  the  three  staphylococcal strains belonging to phage Types 
71, 75, and 81, respectively. All staphylococcal cultures contained comparable 
CFU/ml (approximately 109/ml) and were in early logarithmic phase. At this 
phase of growth, no in vitro bactericidal activity was demonstrable in the fil- 
tered supernatant fluids of all three staphylococcal cultures. Controls of fresh 
TSB and a filtered supernatant fluid of a culture of strain C55 (phage Type 71) 
at  the  same phase  of  growth were  also mixed with  equal volumes of  the  M 
Type 57 culture. From the various mixtures, 0.1 ml samples were injected into 
the backs of hamsters. By 24 hr, the experimental lesions had developed into 
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the crusted stage (15). At this time, cultures were taken from each lesion and 
the number of viable streptococci determined. 
The results are shown in Fig.  1. The circles in each panel represent colony 
counts of surviving streptococci in individual lesions produced under identical 
conditions and the lines are the means for the groups. All lesions in the TSB 
control group (first panel) contained large numbers of viable streptococci. The 
frequency and numbers of streptococci recovered from mixed lesions containing 
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FIG.  1.  Effect of whole cultures or culture supernates of three strains of staphylococci 
representing different phage types on recovery of Type 57 streptococci  from mixed lesion. 
a strain of phage Type 81 staphylococci (second panel) were comparable to the 
TSB control. The strain of phage Type 75 staphylococci tested (third panel) 
resulted in a moderate reduction in the average number of viable streptococci 
recovered; however, streptococci were present in all lesions. With the prototype 
strain of phage Type 71 staphylococci a marked bactericidal effect was often, 
but not invariably, demonstrated (fourth panel). In 6 of 11 lesions, streptococci 
were not detectable and  of the remMning six,  streptococci were significantly 
reduced in three. Since phage Type 71 staphylococci have been shown to pro- 
duce a bactericidal substance which is detected in supernatant fluids (10), the 
in vivo effect of sterile supernatant fluids of phage Type 71 staphylococci when 
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also examined (fifth panel). No effect on the recovery of streptococci from the 
lesions was demonstrated. This suggests that the reduction in viability noted 
with phage Type 71 staphylococci was not due to preformed bactericidal sub- 
stance undetectable in the in vitro system. 
A previous report from this laboratory (10) indicated variations among strains 
of different streptococcal M  Types in their in vitro susceptibility to the bac- 
tericidal substance. Experiments were designed, therefore, to determine whether 
such variations in susceptibility can also be demonstrated in vivo as well as in 
vitro. 
The in vitro susceptibility of the prototype strain of M Type 57 streptococcus 
was  compared to  that  of an  M  Type 12  streptococcus by  spotting  twofold 
dilutions of a supernatant fluid from a 36 hr culture of strain C55 staphylococ- 
cus onto lawns of the two streptococcal strains. The M  Type 57 strain was sus- 
ceptible to a  1:4 dilution of the fluid whereas the M  Type 12 strain was sus- 
ceptible only to undiluted fluid. The in vivo susceptibilities of these two strep- 
tococcal strains were also  compared. Logarithmic-phase organisms  of the M 
Type 12 strain and the M  Type 57 strain (1.2  X  108 CFU/ml and 1.5  X  108 
CFU/ml,  respectively) were each mixed with equal volumes of cultures  of a 
strain of phage Type 71 or 75 S. aureus. 24 hr after intradermal injection of the 
various mixtures,  the number  of viable  streptococci was  determined in  each 
lesion as described above. The results are illustrated in Fig.  2.  Both strepto- 
coccal types are consistently recovered in high numbers from lesions containing 
the  phage  Type 75  staphylococcal strain.  Results  with  the  phage  Type 71 
staphylococcal strain varied strikingly in individual lesions but in general the 
bactericidal effect was more evident with M  Type 57 than with Type 12 strep- 
tococci. This  finding  is  consistent with  the  in  vitro observations mentioned 
above. 
In all of the previously described experiments, streptotocci and staphylococci 
were simultaneously injected into  the hamster.  Additional experiments were 
carried out to assess  whether the superimposition of staphylococci on preexist- 
ing streptococcal lesions would result in demonstrable reduction of viable strep- 
tococci. Lesions were initiated  in  hamsters  using  M  Type 57  streptococcus. 
24 hr later, 0.1  inl of logarithmic-phase cultures of phage Types 71,  75,  or 81 
S. aureus was injected separately into the lesions. Cultures of the lesions were 
taken by calibrated loop 24 hr after the injections of staphylococci. The num- 
ber of viable streptococci was determined as above and the results are shown 
in Fig. 3. As compared with phage Types 75 and 81 staphylococci, phage Type 
71  S.  aureus  resulted in a  moderate reduction in viable streptococcal CFU in 
some lesions, but the reduction in mean count was much less marked than in 
previous experiments when the staphylococci and streptococci were simultane- 
ously injected. 
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CFU/ml  or  greater  as  compared  to  staphylococcal inocula  of  109  CFU/ml. 
The  effect  of  smaller  streptococcal  inocula  was  next  investigated.  Previous 
studies in  the hamster (15)  have shown that  the intradermal introduction  of 
less than 106 CFU/ml of M  Type 57 streptococci/injection  site does not result 
in any noticeable lesion unless a foreign body is incorporated with the inoculum. 
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FI6.  2.  Susceptibility of strains of streptococci representing two different streptococcal  M 
Types to phage Type 71 staphylococci  in mixed lesions. 
Therefore, talcum powder, 1 mg/ml, was added to a logarithmic-phase culture 
of M  Type 57 streptococci diluted to contain 106 CFU/ml.  Equal volumes of 
the streptococcal suspension were added to a logarithmic-phase culture of C55 
staphylococci containing 109 CFU/ml. A control of the same streptococcal sus- 
pension mixed with TSB was also used. Various sites were injected in hamsters 
and the number of viable streptococci from each lesion determined 24 hr after 
the injections. The results are shown in Fig. 4. In 8 of 12 lesions injected with 
the mixture of streptococci and staphylococci, no streptococci were recovered; 
however, in four lesions the numbers of streptococci recovered were comparable 
to the controls. As compared to the previous experiments (Figs.  1 and 2),  the 
bactericidal effect of phage Type 71 S. aureus is generally more pronounced with 
smaller streptococcal inocula, but this effect is not universal. The bimodal dis- ADNAN  S.  DAJANI  AND  LEWIS  W.  WANNAMAKER  593 
tribution of results in the above experiment, which is also suggested in earlier 
experiments, makes the mean value nonrepresentative of the  group.  In  view 
of this marked variation in the in vivo bactericidal activity in individual lesions 
containing identical mixtures of streptococci and phage Type 71 staphylococci, 
various possibilities were explored in an attempt to fred a plausible explanation 
for this observation. 
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FIG. 3. Effect of delayed inoculation of phage Type 71  staphylococci into  preexisting 
streptococcal  lesions on subsequent recovery of Type 57 streptococci. 
The possibility that resistant variants of streptococci might be selected in 
vitro or in vivo was investigated. Using lower concentrations of the bactericidal 
substance in the lawn-spotting method (10), colonies formed by survivors can 
be detected uniformly within the area of killing. Subcultures of three individual 
surviving colonies for each streptococcal Type (M  57  and M  12)  were tested 
for susceptibility to the action of the bactericidal substance. All were sensitive 
and comparable to controls from the original frozen specimens. Also stepwise 
development  of  resistance  did  not  occur when  colonies  formed by survivors 
were picked, subcultured, and tested for four consecutive times. 
Three isolates  of M  Type 57  streptococci recovered from lesions where no 
inhibition was demonstrable were tested in vitro for susceptibility to the action 
of the  bactericidal  substance.  The lawn-spotting method was employed (10). 
All the isolates tested were susceptible and were comparable to a  nonselected 594  INTERACTION  BETWEEN  STAPHYLOCOCCI  AND  STREPTOCOCCI 
control. Thus, selection of mutants which are resistant to the action of the bac- 
tericidal substence does not seem to be the mechanism involved. 
S.  aureus  isolates from various lesions were also studied for possible altera- 
tions in capacity to produce the bactericidal substance. An isolate from a lesion 
showing eradication of streptococci was compared to one from another lesion 
where no inhibition  of streptococci occurred.  Both isolates were grown sepa- 
rately in TSB for 36 hr, and the supernatant fluids harvested. Bactericidal ac- 
tivities in the filtered supernatant fluids were identical. In vivo comparison of 
the two staphylococcal isolates was also investigated. Equal numbers of CFU 
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Fio.  4.  Susceptibility of streptococci to the action of the bactericidal substance in lesions 
initiated with inocula containing talcum powder and smaller ratios of streptococcito staphy- 
lococci. 
of logarithmic-phase  cultures  of  the  two  staphylococcal isolates  were  mixed 
separately with M  Type 57  streptococci. From each mixture, 0.1  ml samples 
were injected intradermally into hamsters at 16 different sites. 24 hr later the 
numbers of viable streptococcal CFU in the 16 lesions were determined as de- 
scribed previously. Results similar to those previously obtained (Fig.  1, panel 
4)  were observed; that is, with both staphylococcal isolates a  wide scatter in 
the number of streptococcal CFU recovered from comparable individual lesions 
was again noted. 
Attempts were made to demonstrate directly the presence of bactericidal ac- 
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cocci.  When tested by the lawn-spotting method, no such  activity could be 
shown in pus or in infected skin rendered sterile by boiling for 10 rain, a pro- 
cedure that does not inactivate the in vitro-produced bactericidal substance. 
In  addition, no activity could be demonstrated in similarly treated material 
obtained from mixed lesions in which streptococci had been eradicated by the 
phage Type 71 staphylococci. When bactericidal substance preformed in vitro 
was mixed with pieces of normal hamster skin or with excised lesions containing 
one or both organisms and the mixtures boiled, no reduction in the titer  of 
bactericidal activity resulted. These findings suggest that the bactericidal sub- 
stance is not inactivated by normal or infected tissues but, if produced in vivo, 
apparently dissipates rapidly. 
DISCUSSION 
Microbial antagonism is an observation of long-standing (17) and has been 
demonstrated both in vitro (9, 10, 18) and in vivo (1%23). Interaction among 
microbial agents may be a significant factor in the ecology of such flora in man. 
A  disturbance in the balance of the normal flora is thought to contribute to 
certain disease processes,  particularly in the gastrointestinal tract (24).  Since 
staphylococci are  common inhabitants  of the  respiratory  tract,  conjunctiva, 
and skin of humans, their possible role in microbial interaction has received some 
attention. Halbert  et  al.  (20)  have demonstrated the  protective effect of S. 
epidermidis  in mice against infections with Clostridium  septicum.  They have 
also  demonstrated protection  in  guinea  pigs  against  Corynebacterium diph- 
theriae infection (21).  The staphylococci employed in those studies were orig- 
inally isolated from human conjunctivae. S. epidermidis  strains producing an 
antibiotic substance in vitro were the only staphylococci that were protective 
in vivo. Interference among staphylococci has been  demonstrated in experi- 
mental animals (19, 23)  and colonization with S. aureus strain 502A has been 
used to prevent infections or colonization with heterologous staphylococci in 
humans (22).  Strain 502A is not a phage Type 71 or Group II staphylococcus 
and produces no bactericidal substance in vitro (10). 
Bacterial interaction in relation to skin infections has not been investigated 
extensively. Anthony and Wannamaker (19) have demonstrated bacterial in- 
terference among various staphylococci in experimental burns in the rabbit. In 
this animal model,  antagonism is  not restricted to  particular  staphylococcal 
strains. The mechanism(s) by which such bacterial antagonism occurs has not 
been clearly elucidated in this model or in many of the other in vitro or in vivo 
models described. It is possible that several mechanisms exist. 
The availability of an experimental model for impetigo (14, 15) has enabled 
the study of the interaction between staphylococci and streptococci in vivo, as 
reported in the present study. The results indicate that microbial antagonism 
between phage Type 71 staphylococci and Group A streptococci does occur in 596  INTERACTION  BETWEEN  STAPHYLOCOCCI AND  STREPTOCOCCI 
vivo. Moreover, in this model, antagonism is not demonstrated by strains of 
several  other  staphylococcal  phage  types  tested.  The  mechanism  by which 
phage Type 71 S.  aureus kills other organisms in vitro has been reported (12). 
It is  tempting  to assume that  the same mechanism may be operable in vivo 
although we have no direct evidence to support this view. The relationship of 
the bactericidal substance from phage  type 71  staphylococci to bacteriocins 
has been discussed at length in a previous report (11). Evidence consistent with 
the possibility that a  well-defined staphylococcal bacteriocin may play a  role 
in bacterial antagonism in vivo has not to our knowledge been reported previ- 
ously. 
Bactericidal activity could be demonstrated best when mixtures of staphylo- 
cocci and streptococci were simultaneously injected into animals. Superimposi- 
tion  of  staphylococci  on  preexisting  streptococcal lesions  resulted  in  a  less 
marked  bactericidal  activity. The reason for this  difference is  not  clear but 
could be due, at least in part, to technical difficulties in assuring adequate mix- 
tures of organisms in vivo. In many instances, part of the superimposed staphy- 
lococcal inoculum leaked out of  the  lesions. The  duration  of  contact  of  sus- 
ceptible cells  with the liberated bactericidal substance, the phase of growth of 
the cells,  or the rate of production of the substance may also  be responsible 
factors.  Furthermore, the number of streptococcal  CFU  in  the lesions  could 
have increased in the 24 hr before superimposition of the staphylococci resulting 
in a high ratio of streptococci to staphylococci. In the animal burn model (19) 
a  minimal  time interval  was  required between inoculation of the interfering 
strain and inoculation of the challenge strain for interference to be manifested. 
Variations in the in vitro susceptibility of streptococcal strains of different M 
Types have  been noted previously (10),  and  similar results were obtained in 
vivo in the present studies. M  Types 57 and 49 are  more susceptible in vitro 
than M  Types 12 and 14.  The present in vivo studies demonstrate further the 
greater sensitivity of  M  Type 57  as compared to M  Type  12.  The  biological 
properties of the streptococcus responsible for this  difference in susceptibility 
require further study. 
The wide variation in bactericidal effect in individual lesions produced by 
the same inocula is intriguing and deserves some discussion. Of particular in- 
terest is the tendency toward a bimodal distribution in the numbers of surviv- 
ing streptococci, with some lesions showing no reduction in viable count and 
others showing complete killing  of streptococci. This  tendency was  noted in 
most  experiments  but  was  particularly  striking  when  a  small  streptococcal 
inoculum and a foreign body were used. 
No explanation of this phenomenon has been obtained. Selection of resistant 
mutants in vitro or in vivo among M Type 57 streptococci could not be demon- 
strated in the present studies. No correlation could be shown between survival 
of streptococci in mixed lesions in the hamster and lack of production of the 
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no evidence of in vitro selection of staphylococci to become incapable of pro- 
ducing the bactericidal substance has been demonstrated. A possible explana- 
tion, however, is that only a few staphylococcal cells in a given population are 
capable  of producing  the bactericidal  substance,  some  evidence for which is 
available in other systems. Ozeki eL al. (25), using micromanipulative isolation 
technics, demonstrated that only 1% of a S. typhimurium population is capable 
of producing bacteriocins. Using a  modification of the soft agar layer method 
described by these workers (25)  we have been unable to demonstrate the same 
phenomenon with staphylococci. Irrespective of the exact explanation for this 
biological variation, it remains an interesting  experimental finding since it is 
consistent  with  the  observation  that  occasionally in  human  impetigo  phage 
Type 71  staphylococci are  recovered  along with  streptococci from the same 
lesion (1, 2, 5, 6). 
SUMMARY 
The interaction between staphylococci and  Group A beta hemolytic strepto- 
cocci in mixed lesions was investigated in an experimental impetigo model. A 
strain of staphylococcus of phage Type 71,  which has been shown in vitro to 
produce  a  bacteriocin  for  streptococci  and  other  Gram-positive  organisms, 
eliminates or reduces Group A streptococci in mixed lesions. In contrast, staphy- 
lococcal strains of phage Types 75 and 81, which do not produce a  demonstra- 
ble bacteriocin in vitro, exhibit no such effect. 
Some variation was noted in the in vivo response of two different streptococ- 
cal M Types to the bactericidal effect of phage Type 71 staphylococci. Bacterial 
antagonism is  more pronounced  when staphylococci and  streptococci are in- 
jected simultaneously into animals than  when staphylococci are superimposed 
on preexisting streptococcal lesions. 
Marked variations were found in the numbers of viable streptococci (colony- 
forming units)  recovered from individual lesions containing identical mixtures 
of streptococci and phage Type 71  staphylococci. The frequency of a  demon- 
strable bactericidal effect was related  to the number of streptococci injected. 
With small inocula of streptococci, the tendency towards an  all-or-none effect 
was particularly striking. No evidence of selection of streptococcal or staphylo- 
coccal mutants which might explain this phenomenon was obtained. 
These  observations  suggest  that  the  bactericidal  effect of phage  Type 71 
staphylococci on other Gram-positive organisms,  previously demonstrated in 
vitro, appears to operate also in vivo. 
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